Aligos Therapeutics, Inc. · NASDAQ:ALGS
Aligos Therapeutics, Inc. shareholders
As of Jun 30, 2026, 30 institutions reported holding Aligos Therapeutics, Inc., 36.7% of its shares. Largest: Deep Track Capital, LP, Alyeska Investment Group, L.P. and Sio Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aligos Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Deep Track Capital, LP | 444K | 7.1% | no change | Aug 14, 2026 |
| Alyeska Investment Group, L.P. | 412K | 6.6% | no change | Aug 14, 2026 |
| Sio Capital Management, LLC | 327K | 5.2% | no change | Aug 14, 2026 |
| Marshall Wace, LLP | 247K | 3.9% | −20,556 | Aug 13, 2026 |
| Vanguard | 204K | 3.3% | −2,544 | Aug 13, 2026 |
| Woodline Partners LP | 177K | 2.8% | no change | Aug 14, 2026 |
| Baker Bros. Advisors LP | 83,055 | 1.3% | no change | Aug 14, 2026 |
| Hhlr Advisors, LTD. | 76,247 | 1.2% | held for review | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | 66,463 | 1.1% | +55,485 | Aug 14, 2026 |
| UBS | 59,986 | 0.96% | +22,925 | Aug 13, 2026 |